Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
BETHESDA, Md., April 12, 2023 -- Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced the appointment of... | June 19, 2023